Glenmark Life Sciences Limited (GLS.BO)
INR 1085.8
(0.0%)
INR 1085.8
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.5 Billion INR | 5.49% |
| 2022 | 27.02 Billion INR | 9.35% |
| 2021 | 24.71 Billion INR | 23.73% |
| 2020 | 19.97 Billion INR | 15.73% |
| 2019 | 17.25 Billion INR | 16.96% |
| 2018 | 14.75 Billion INR | 1735658.82% |
| 2017 | 850 Thousand INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 30.84 Billion INR | 0.0% |
| 2023 Q2 | 29.52 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 28.5 Billion INR | 5.49% |
| 2023 Q4 | 28.5 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 26.81 Billion INR | 0.0% |
| 2022 FY | 27.02 Billion INR | 9.35% |
| 2022 Q4 | 27.02 Billion INR | 0.0% |
| 2021 Q2 | 23.29 Billion INR | 0.0% |
| 2021 FY | 24.71 Billion INR | 23.73% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 24.71 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 Q4 | 19.97 Billion INR | 2.07% |
| 2020 Q3 | 19.56 Billion INR | 0.0% |
| 2020 FY | 19.97 Billion INR | 15.73% |
| 2019 FY | 17.25 Billion INR | 16.96% |
| 2018 FY | 14.75 Billion INR | 1735658.82% |
| 2017 FY | 850 Thousand INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 55.777% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 93.676% |
| Granules India Limited | 55.2 Billion INR | 48.371% |
| Indoco Remedies Limited | 21.44 Billion INR | -32.903% |
| Achyut Healthcare Limited | 309.52 Million INR | -9109.077% |
| Ajanta Pharma Limited | 46.38 Billion INR | 38.547% |
| Alkem Laboratories Limited | 155.74 Billion INR | 81.699% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1460.829% |
| Brooks Laboratories Limited | 904.45 Million INR | -3051.528% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -164.41% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -272.541% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -134.821% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 92.644% |
| Eris Lifesciences Limited | 70.48 Billion INR | 59.562% |
| FDC Limited | 24.68 Billion INR | -15.491% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 80.148% |
| Gufic Biosciences Limited | 10.92 Billion INR | -160.897% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -144.648% |
| Ipca Laboratories Limited | 111.01 Billion INR | 74.324% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1213.082% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1499.785% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1789.333% |
| Laurus Labs Limited | 83.87 Billion INR | 66.014% |
| Lupin Limited | 239.97 Billion INR | 88.122% |
| Mankind Pharma Limited | 119.63 Billion INR | 76.174% |
| Medicamen Biotech Limited | 2.94 Billion INR | -867.808% |
| Medico Remedies Limited | 961.95 Million INR | -2863.151% |
| Megasoft Limited | 3.65 Billion INR | -679.015% |
| NATCO Pharma Limited | 69.06 Billion INR | 58.727% |
| Piramal Pharma Limited | 153.11 Billion INR | 81.384% |
| RPG Life Sciences Limited | 5.12 Billion INR | -455.777% |
| Sigachi Industries Limited | 6.94 Billion INR | -310.63% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 96.665% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -26.455% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -604.39% |
| Unichem Laboratories Limited | 31.69 Billion INR | 10.063% |
| Wanbury Limited | 3.43 Billion INR | -729.831% |
| Windlas Biotech Limited | 6.26 Billion INR | -355.188% |
| ZIM Laboratories Limited | 4.46 Billion INR | -537.93% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 90.265% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -453.435% |
| Divi's Laboratories Limited | 154.7 Billion INR | 81.575% |
| Hester Biosciences Limited | 6.62 Billion INR | -330.35% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -258.831% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -676.953% |
| Bal Pharma Limited | 3.2 Billion INR | -789.672% |
| Strides Pharma Science Limited | 58.39 Billion INR | 51.19% |
| Venus Remedies Limited | 6.26 Billion INR | -354.734% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -10.391% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -30.093% |
| Shilpa Medicare Limited | 30.93 Billion INR | 7.849% |
| Aarti Drugs Limited | 24.32 Billion INR | -17.187% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -27.001% |
| Suven Life Sciences Limited | 2.84 Billion INR | -900.486% |
| Ind-Swift Limited | 6.54 Billion INR | -335.529% |
| Valiant Laboratories Limited | 3.42 Billion INR | -731.782% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 28.635% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -21.245% |
| Themis Medicare Limited | 5.66 Billion INR | -403.236% |
| Hikal Limited | 24.87 Billion INR | -14.606% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 81.074% |
| Sequent Scientific Limited | 15.4 Billion INR | -85.046% |
| Novartis India Limited | 9.24 Billion INR | -208.176% |
| Wockhardt Limited | 76.49 Billion INR | 62.735% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 75.318% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -5954.054% |
| Neuland Laboratories Limited | 18.32 Billion INR | -55.543% |
| Morepen Laboratories Limited | 12.93 Billion INR | -120.415% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -1087.367% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -754.891% |